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The prevalence of human papillomavirus (HPV) in the oral 
cavity and oropharynx has not yet been as well studied as its 
infection of the vaginal tract. However, new study are emerge 
after the development of molecular biology techniques. The 
objective of this study is to show the prevalence of HPV in 
the oral cavity and the oropharynx. An ample bibliographic 
review was done showing a prevalence of HPV 6, 11 in a 
normal oral mucous membrane (latent infection). In oral 
benign lesions associated with HPV, a prevalence of HPV 6 
and 11 was observed in squamous cell papilloma (SCP) and 
condylomas acuminatum, while HPV 2 and 57 were more 
prevalent in verruca vulgaris lesions. As for focal epithelial 
hyperplasia (FEH) and oral cancer, especially squamous cell 
carcinoma (SCC), the prevalence was of HPV 13 and 32, 
and HPV 16, respectively. The last findings are, nonetheless, 
controversial. The last findings are, nonetheless, controversial. 
Showed also discrepancy result the prevalence of human 
papillomavírus (HPV) in normal oral mucous (latent infection) 
and in oral cancer, however evidenced confirmatory result 
in oral benign lesions associated with virus.
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INTRODUCTION
HPV is the acronym used to identify the human 
papillomavirus, responsible for the condiloma acuminata 
(from the Greek term kondilus = round tumor and the 
Latin term acuminare = make it pointed)1.
Human papillomavirus belong to a large family of 
viruses, the papovaviridae. They are small (about 55nm in 
diameter) and epitheliotropic. Their genome is made up 
of 7,200 - 8,000 base pairs with molecular weights of 5.2 x 
106 Daltons. They have a capsule with 72 capsomeres of 
icosahedral structures, without lipoprotein envelope, and 
in a single circular double DNA molecule2-5.
Human papillomavirus infections and its spread oc-
cur all over the world. HPV infect the skin and mucosas and 
might induce the formation of both benign and malignant 
tumors6. The infection starts when the virus penetrates 
the new host, through micro-injuries. The development of 
this incubation phase into active expression depends on 
three factors: cell permeability, virus type and the host’s 
immune status7.
HPV prevalence in the normal oral mucosa (latent 
infection) and its relation to oral cancer have generated 
conflicting opinions. The discrepancy observed is mainly 
attributed to a variation in the sensitivity of the methods 
employed and epidemiologic factors related to the group 
of patients examined8.
The goal of the present study is to carry out a 
bibliographic review on the prevalence of human pap-
illomavirus in the oral cavity and oropharynx through 
HPV detection methods, immunohistochemistry, in situ 
hybridization, Southern blot hybridization and polymerase 
chain reaction, checking the HPV types prevalent in the 
normal oral mucosa (latent infection), in benign oral and 
oropharynx lesions (squamous cells papilloma, condiloma 
acuminata, common wart and focal epithelial hyperplasia), 
and in oral cancer.
LITERATURE REVIEW
HPV detection methods
The diagnosis of human papillomavirus in the oral 
mucosa may be suspected when one inspects the lesion, 
and also through cytology and biopsy. The cytological 
aspect of the HPV infection is characterized by: 
A. Major criteria: classic coilocytes, perinuclear 
cytoplasmic halos and nuclear dysplasia.
B. Minor criteria: dysceratocytes, atypical immature 
metaplasia, macrocyte and binucleation. This method bears 
limited sensitivity and does not type the HPV9,10.
The methods used to detect the HPV DNA in le-
sions vary broadly as far as their sensitivity and specificity 
are concerned11. These are further broken down in three 
categories: 
Low Sensitivity: immunohistochemistry and in situ 
hybridization - because they only detect the virus when 
it is present in more than 10 copies of the viral DNA per 
cell.
Moderate Sensitivity: Southern blot, dot blot and 
reverse dot hybridizations, because they only detect the 
virus when present in 1 to 10 copies of the viral DNA per 
cell; and the High Sensitivity: PCR, because it detects the 
virus in less than 1 copy of the viral DNA per cell12.
Immunohistochemistry may detect the protein coat 
of HPV viral particles which are present in the lesions seen 
under light microscopy in paraffin bearing material or in 
cytological preparations, and in these cases, polyclonal 
antibodies are used against different types of HPV specific 
antigens9. This technique is hampered by the limited avail-
ability of antibodies against specific types of HPV, since 
the virus does not replicate in vitro. Commercially avail-
able antibodies are created against bovina papillomavirus 
capsule antigens, with an HPV crossed reaction13.
Hybridization tests are currently the methods of 
choice to detect HPV DNA or RNA in smears or tissue 
samples. They are made directly or after DNA and RNA 
amplification through PCR. The basic principle behind 
these hybridization techniques is the double formation 
between the DNA single strand, RNA molecules or cloned 
HPV types, denaturated DNA derivatives and viral nucleic 
acid molecules present in the cell, which represents the 
hybridization test target10.
The Southern blot hybridization is used in order to 
detect the HPV DNA from biopsies and is considered the 
“gold standard” to detect HPV genome. It is a sensitive and 
highly specific test, thus proving to be a valuable research 
tool, however it has no application in clinical routine tests 
because it takes longer and it requires harder work10.
Another recently developed hybridization method 
is the hybrid capture (HCA), which does not distinguish 
among the specific HPV types; and their applicability as 
a research method is limited, however it may represent a 
good test for routine clinical use10.
Polymerase Chain Reaction (PCR) is a technique 
that has revolutionized virology, because of its extremely 
high sensitivity5. It is characterized by the amplification of 
minute amounts of target DNA sequences in many million 
times. It is a cyclic thermal process that includes three 
stages: denaturation, in which the double DNA strand is 
separated in single strains; coupling, in which the primers 
couple specifically with their complementary single strand 
target-DNA sequences; and finally, the primer extension, 
in which a thermostable DNA polymerase generates DNA 
“offspring” strands which cross the region between two 
primers. From then on, recently generated double strands 
serve as models for a subsequent PCR cycle. The primers 
may be: type-specific primers, which detect a simple type 
of HPV, or the consensus primers (also called general or 
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generic), which detect a whole array of different HPV types 
in a single reaction14.
PCR detection of HPV is usually carried out through 
one of the consensus primers, the MY09-MY11 or the 
GP5/GP610,15. Currently, PCR allows for a more in depth 
assessment of epidemiologic data, including the prevalence 
of latent of subclinical infections. However, it bears the 
following disadvantages: amplification of minute amounts 
of contaminating HPV DNA, which may lead to false-
positive results. Each method is limited by its sensitivity, 
specificity, its practice, cost and its commercial availability. 
It is important and fundamental to assess the efficacy of 
different HPV detection techniques, in order to establish 
HPV etiology in oral lesions10,16.
Human papillomavirus prevalence in the oral cavity and 
oropharynx
HPV prevalence in the oral cavity and oropharynx 
is uncertain. Studies have shown dubious results, assessing 
a small number of patients and identifying some of the 
many HPV types found in mucosal lesions17.
So far, over 100 types of HPV have been 
identified18,19. Of these, 25 types have been associated 
to oral lesions (HPV-1, 2, 3, 4, 6, 7, 10, 11, 13, 16, 18, 31, 
32, 33, 35, 40, 45, 52, 55, 57, 58, 59, 69, 72 and 73)20.
In order to explain the HPV infection relationship 
with many oral lesions, it is important to investigate HPV 
prevalence in the normal oral mucosa.
Human papillomavirus prevalence in normal oral mu-
cosa
Papillomavirus in normal oral mucosa must be in-
vestigated throughout studies on oral cavity HPV infection 
natural history. Its prevalence in the normal oral mucosa 
is controversial21.
In the normal oral mucosa we have seen a great 
variation in HPV rates detected, from 22% to 60%17; from 
0% all the way to 81.1% in studies using different methods, 
and with a limited number of individuals, and this seems 
to depend on the population studied and the choice of 
method16,21. It has been suggested that HPV prevalence 
in the normal mucosa includes subclinical and/or latent 
infections, and that the infection with a low number of 
virus copies is common in the oral cavity8.
Table 1 depicts the techniques and the results ob-
tained by different authors as to the identification of the 
HPV type in the normal oral mucosa.
Human papillomavirus prevalence in benign lesions 
(squamous cells papilloma, condiloma acuminata, common 
wart and focal epithelial hyperplasia of the oral cavity and 
oropharynx related to the virus).
Oral and oropharynx squamous cells papilloma 
are benign tumors that occur mainly between 30 and 
50 years of age, although they may also occur below 10 
years of age22. They represent about 8% of oral tumors 
in children23.
They usually involve the soft palate, tongue, frenu-
lun linguae and the lower lip. In most of the cases, the 
papillomas are single and small (<1cm)24. They have an ex-
ophytic growth and show up both as a broad based ovoid 
bulging, or a pedicled lesion. The surface may present 
small finger-like projections, giving it a rough verruca 
contour. The color varies from white to pinkish, depending 
on the levels of keratinization and vascularization25.
Oropharynx and oral condiloma acuminata 
Oral condiloma acuminata is usually considered 
a sexually transmitted disease, acquired by oral sexual 
contact. Currently, the trend is to consider that the 
oral condiloma may be acquired not only by oral Sex, 
but also by self inoculation or as a result of maternal 
transmission20,25,26.
Clinical and histological similarities between squa-
mous cells papilloma, condiloma acuminata and verruca 
in the oral cavity are clear27. This differentiation with PCE 
is difficult and purely academic. In the mouth they are 
usually present as small pinkish or whitish nodules, which 
spread in papillary projections and may be pedicled or 
sessile. The surface contour, in most of the cases, is cauli-
flower-like rather than papillomatous24. They occur alone 
or in multiple form, frequently on the tongue, lip, palate 
and floor of the mouth28.
In the genital tract, the terms papilloma and con-
diloma were used separately, until the year 1970; since 
then, both lesions are called condiloma. This modification 
may also be applied to oral lesions, because both the 
papilloma and the condiloma have the same HPV types 
found in genital condilomas20.
The human papillomavirus was detected in condilo-
matous oral lesions, initially by immunohistochemistry, 
and later by hybridization techniques, with a positiveness 
varying between 75% to 85% for HPV 6 and 1120,24.
In 1991, Zeuss et al.29, considered HPV 6 and 11 
as being the types most frequently associated to benign 
papillomatous oral lesions.
Oral and oropharynx common wart
The common wart is one of the most common 
skin lesions, specially in children24. They are clinically 
undistinguished from PCE and condiloma, appearing as 
a sessile papillomatous whitish lesion of rough surface25. 
They are frequently located on the lips, hard palate, gums 
and tongue dorsum30. The diagnosis of an oral wart must 
be restricted to a lesion with clinical and histological 
characteristics of a common skin wart, and confirmed by 
seeing the HPV types in the skin wart20.
Many authors showed the presence of the virus in 
oral warts by immunohistochemistry and hybridization 
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Table 1. Results from various authors as to HPV identification in the normal oral mucosa.
Year Investigator Method # P / # . C % HPV type
1992 Kellokoski et al. 29 PCR 18 / 78 (23) 6, 11 e 16(83%), 18(17%)
SB 33/212 (15) 2,6,11,13,16,18
1992 Jalal et al. 27 PCR 21 / 48 (44) 16
1993 Holladay and Gerald. 25 PCR 1 / 6 (17) 16
1995 Eike et al.16 PCR 0 / 61 0 -
1995 Mao et al. 34 PCR 4 /26 (15) 16
1996 Tominaga et al. 76 PCR 3 / 3 (100) 6
SB 0 / 3 0 -
1996 Cruz et al. 11 PCR 0 /12 0 -
1996 Mao et al. 35 PCR 0 / 6 0 -
1998 D´Costa et al. 12 PCR 15 /48 (31) 16
1998 Badaracco et al. 4 PCR 4 / 22 (18) 6(20%),16(50%), 31,11(10%)
1999a Terai et al. 72 PCR 26/30 (87) 18(87%), 61(60%), 59(23%), 16( 7%)
1999 Pillai et al. 51 ISH 0 / 10 0 -
1999 Bustos et al.8 ISH 0 /33 0 -
2003 Surgyama et al. 64 PCR 16/44 (36) 16
#= number; P = positives; C = cases; ISH =in situ hybridization; SB = Southern blot hybridization; PCR = polymerase chain reaction.
tests. They observed a variation in the HPV detection rates 
from 43% to 100% in oral warts29, 31,32.
HPV prevalence in oral warts seems to be HPV 2, 
followed by the HPV 57, although more studies are neces-
sary to identify the broad spectrum oral infectiosn caused 
by skin HPV types20,33.
Table 2 shows the techniques and the results of the 
studies about papillomas, condilomas and warts in the oral 
cavity and oropharynx.
Oral focal epithelial hyperplasia (FEH) 
The term focal epithelial hyperplasia (FEH), or 
Heck’s disease, introduced by Archard et al.34 in 1965, to 
describe multiple nodular elevations in the oral mucosa 
observed in Alaska Eskimos and North and South American 
Indians. It is rarely observed in caucasians35. It has also 
been described in Israel, South Africa and Sweeden36.
It is a benign lesion that may be located in the oral 
mucosa, lips and tongue, and most notably in the lower 
lip24, 37, 38. It is clinically characterized by multiple painless 
and soft papules, of color that varies between pale pink 
and the normal mucosal color. A strong family history has 
been suggested by a number of authors24,25,50.
Viral etiology has been initially shown by immuno-
histochemistry and later on by hybridization techniques 
identifying HPV 13 and 32, which were detected in 75-
100% of the cases32.
HPV 13 and 32 were considered specific in focal 
epithelial hyperplasia, however, HPV 32 was also found in 
other oral lesions, but never outside the oral cavity36,39,40.
The studies and their results are depicted on table 
3.
Human papillomavirus prevalence in oral cancer and 
oropharynx 
Unfortunately, oral cancer still bears high mortality 
rates. Its incidence rate varies from one region to another, 
being high in India, Sri Lanka, Vietnam, Filipinas, Hong 
Kong and Taiwan, where about 30% of all the cancers 
occur in the oropharynx. India has approximately 56,000 
new cases per year, and is probably among the highest 
incidence rates in the world41.
It is a disease that affects patients in their 50th 
decade of life, being more evident between 60 and 70 
years of age. Oral cancer includes malignant neoplasms 
in the lips, oral cavity and oropharynx42. Oral cancer is 
a severe and growing public health concern in Brazil, 
corresponding to 4% of all cancer types, occupying the 
eighth place among the tumors that affect men, and the 
11th among women43.
The most common location for oropharynx cancers, 
is the palatine tonsils. Notwithstanding, lingual cancer cor-
responds to 30% of these44. About 90% of these lesions are 
located in soft tissues and are originated from squamous 
epithelium20.
Cigarette smoking and alcohol are the main causes 
of oral cancer. They act in synergy and are a dose-
dependent12,17. However, part of the population develops 
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Table 2. Results from various studies as to HPV identification in papillomas (including condiloma and wart) in the oral cavity and oropharynx.
Year Investigator Lesion Method #. P / #. C % HPV type
1986 Adler-Storthz et al.78 Verruga IHQ 6 / 11 (55) HPV +
ISH 6 / 11 (55) 2 (83%), 4 (17%)
1986 Syrjänen.68 Papiloma ISH 6 / 7 (85.5) 6( 33.5%) 11( 66.5%)
IHQ 4 / 7 (57) HPV +
1986 Syrjänen. 68 Condiloma ISH 2 / 2 (100) 6(50%) e 11(50%)
IHQ 2 /2 (100) HPV +
1987 Eversole et al. 18 Condiloma IHQ 5 / 20 (25) HPV +
ISH 18/ 20 (90) 6, 11 (85%), 2(5%)
1991 Zeuss et al.81 Papiloma ISH 4 / 30 (13) 6 e 11
1991 Zeuss et al. 81 Condiloma ISH 15/15 (100) 6 e 11
ISH 11 / 15 (73) 6 ,11, 16, 18, 31, 33, 35
1991 Zeuss et al. 81 Verruga ISH 5 / 5 (100) 6 e 11
1991 Young et al.79 Papiloma ISH 13 /21 (62) 6, 11
10 / 13 (77) 16, 18, 31, 33, 35
1994 Padayachee et al.46 Verruga IHQ 12 / 21 (57) HPV+
ISH 15 / 21 (71) 2 e 57 (87%), 2 (13%)
1995 Padayachee et al. 47 Verruga ISH 14 /19 (74) 2
ISH 12 / 19 (63.5) 57
PCR 8 /19 (43) 2, 57
1996 Tominaga et al.76 Condiloma PCR 1 /8 (13) 6
1998 Bishop et al. 6 Condiloma ISH 1 / 1 (100) 6 e 11
1998 Badaraccoe Condiloma PCR 7 / 7 (100) 6, 31, 57, 56, 44, 16
1999b Terai et al. 73 Verruga IHQ 1 / 1 (100) HPV+
ISH 1 / 1 (100) 2
SB 1 / 1 (100) 2
#= number; P = positives; C = cases; IHQ = immunohistochemistry; ISH =in situ hybridization; SB = Southern blot hybridization; PCR = 
polymerase chain reaction; HPV+ = positive human papillomavirus.
Table 3. Results from various authors as to HPV identification in the oral cavity and oropharynx focal epithelial hyperplasia.
Year Investigator Method #.P / #. C % HPV type
1984 Syrjänen27 IHQ 1 / 1 (100) HPV +
1987 Hernandez-Jauregui et al.35 SB 7 /7 (100) 13
1989 Garlick et al.37 SB 4 /4 (100) 13(75%), 32(25%)
1989 Henke et al.38 ISH 16 / 17 (95) 13(59%), 32(35%)
1991 Padayachee & Van Wyk36 IHQ 7 / 18 (39) HPV +
ISH 15 / 18 (83) 32 (60%), 13 (33%)
11(7%)
2002 Schwenger et al.76 PCR 5 / 5 (100) 13(20%) e 32(60%)
#= number; P = positives; C = cases; IHQ = immunohistochemistry; ISH = in situ hybridization; SB = Southern blot hybridization; PCR = 
polymerase chain reaction; HPV + = positive human papillomavirus.
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Table 4. Results from various authors as to HPV identification in oral carcinoma.
Year Investigator Lesion Method #. P/ #. C % HPV type
1985 De Villiers et al.75 CCE SB 3 / 7 (43) 2, 16
1986 Syrjnänen68 CCE ISH 1 / 2 (50) 16
IHQ 0 / 2 0 -
1991 Zeuss et al.29 CCE ISH 0 / 15 0 -
1991 Young et al.54 CCE ISH 0 / 17 0 -
CV ISH 0 / 10 0 -
1993 Holladay & Gerald.73 CCE PCR 7 /37 (19) 16 e 18
1993 Noble-Topham et al.57 CV PCR 12 /25 (48) 6,11(10%), 16(20%)
18(84%)
1994 Ostwald et al.61 CCE PCR / SB 16 /26 (62) 16(45%), 18(35%)
6,11 (15%)
1995 Balaram et al.46 CCE PCR 67 /91 (74) 6(13%), 11(20%),
16(42%), 18(47%)
CV PCR 10 / 15 (67) 6(10%), 11(20%), 16, 18(60%)
1996 González-Moles et al.72 CCE PCR 11 / 37 (30)
1996 Snijders et al.53 CCE PCR 7 /32 (22) 16
1996 Cruz et al.71 CCE PCR 19 / 35 (55) 16(79%), nd (21%)
1998 Mineta et al.70 CCE PCR 3 / 14 (21) 16
1998 Wilczynski et al.62 CCE PCR 14 / 21 (64) 16(80%), 33(10%),
59(10%)
1998 Premoli-de-Percoco et al.69 CCE ISH 35 / 50 (70) 16 e 18 (80%), 16, 18, 6 e 11(20%)
1998 Miguel et al.60 CCE PCR 2 / 27 (8) 16
1998 Elamin et al.55 CCE PCR 14 / 28 (50) 16(43%),
16 e 6(36%), 6(21%)
1998 D´Costa et al.68 CCE PCR 15 / 100 (15)
1998 Koh et al.67 CCE PCR / SB 22 /42 (52) 16(68%),18 (27.5%)
33(18.5%)
1999 Bustos et al.56 CCE (3/9) ISH 09 /33 (27) 16
CV (5/9)
Melanoma (1/9)
2002 Kojima et al.18 CCE PCR 35 / 53 (66) 38
2003 Sugiyama et al.63 CCE PCR 30 /86 (35) 16
#= number; P = positives; C = cases; IHQ = immunohistochemistry; ISH =in situ hybridization; SB = Southern blot hybridization; PCR = 
polymerase chain reaction; nd= undetermined; CV= verrucous carcinoma; CCE= squamous cell carcinoma.
oral cancer without having been exposed to these risk 
factors, suggesting other causes, such as: genetic predispo-
sition, diet and viral agents, most specifically HPV 345.
The simultaneous presence of chemical agents and 
HPV infection in the oral mucosa may favor the malignant 
transformation46. Notwithstanding, the HPV role as an 
etiological agent in the oral cancer is less than that from 
alcohol and tobacco use because HPV infection preva-
lence is less than alcohol and tobacco use in the genesis 
of oral cancer20,47.
Syrjänen et al.48, in 1983, suggested that HPV may 
be involved in oral cavity squamous cell carcinoma, 
when they described HPV cytopathological alteration in 
oral cancer, identical to those previously found in uterine 
cervix cancer, although we still lack proof by other DNA 
hybridization methods.
Many studies have shown HPV 16 to be the most 
prevalent type in oral cancer, as it happens in anogenital 
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cancer24,25,49.
In a 2001 metanalysis, Miller & Johnstone47, showed 
an HPV increase in oral epithelial carcinoma and dysplasias 
when compared to the normal oral mucosa, mainly in high 
risk genotypes. Results show HPV to be an independent 
risk factor for squamous cell oral carcinoma. In 2003, 
Herrero et al.50, studied HPV in oral cancer and observed 
a higher prevalence of HPV 16 in the oral cavity and the 
oropharynx among patients that had more than one sex 
partner and/or who practiced oral sex, while the lowest 
prevalence was seen among smokers.
According to many studies, the HPV prevalence rate 
in oral cancer varied from 0-100%17,25,29,51-54. This broad vari-
ation in HPV detection rate is explained by the different 
detection methods used in the HPV investigation25.
One of the greatest difficulties in identifying HPV 
in oral cancer patients is the presence of this virus in only 
one subpopulation of cells and the reduced number of 
copies of these cells which are infected. That is why we 
need high sensitivity detection methods55.
Verrucous carcinoma
The verrucous carcinoma was first described as a 
variant of the squamous cells carcinoma, which originates 
in the oral cavity.
Also known as Ackerman’s tumor, its growth is 
exophytic, slow and invasive -only superficially, with a 
low metastasis rate, and it may be treated with simple 
excision. Many authors have reported the HPV presence 
in the verrucous carcinoma20,32,46,56-58.
Squamous cells carcinoma (SCC)
Encompasses about 95% of all the oral cancers. Its 
clinical aspects vary from a nodule up to a chronic ulcer. 
Many researchers have shown HPV present in SCC18,59-62. 
Initially we did microscopy, immunohistochemistry and, 
more recently, molecular biology tests20.
Studies have shown the important role of HPV 
in head and neck cancers, and also suggest that HPV 
16 may be involved in the development of some oral 
carcinomas56,60,63.
Table 4 shows oral carcinoma studies with their 
results and techniques.
MATERIALS AND METHODS
We searched the MEDLINE database and textbooks, 
English and Portuguese medical literature, from January 
1990 to December 2003, and found reports of HPV preva-
lence by virus detection methods (immunohistochemistry 
and molecular biology exams) in the normal oral mucosa, 
in virus-related benign lesions (squamous cells papilloma, 
condiloma, verruca and focal epithelial hyperplasia) and 
in oral cancer.
In the MEDLINE database, we used the follow-
ing keywords: detection, human papillomavirus oral, 
Polymerase Chain Reaction, human papillomavirus, oral 
cavity, normal oral cavity, oral lesions, papillary lesions, 
oral condiloma acuminata, oral warts, oral focal epithe-
lial hyperplasia, oral cancer, squamous cell carcinomas, 
among others, they were used alone or in combination 
in the search.
After we selected these scientific papers we included 
some relevant papers about oral HPV, published before 
the period established in the search string.
DISCUSSION
HPV prevalence in the oral cavity and oropharynx 
is considered uncertain, because many studies have shown 
different results with the estimate of a small number of 
patients, and a modest identification among the different 
types of HPV found in mucosal lesions17.
HPV diagnosis in the oral mucosa and the orophar-
ynx may be suspected by the clinical exam of the lesion, 
cytology and biopsy; however the molecular biology 
exams are the ones able to detect the HPV DNA in the 
cell, stressing the polymerase chain reaction as the most 
sensitive method to detect HPV. Notwithstanding, the 
assessment of different methods used to detect HPV16 
is important and fundamental in order to establish the 
etiological role of HPV in oral lesions.
Table 1 shows HPV 16 prevalence in the normal oral 
mucosa in 16 results from 14 authors, by the SB, ISH and 
PCR detection methods, making up 56% of all the results, 
and this seems to depend on the population examined 
and the choice of method used to detect HPV21,16.
Still table 1 shows 6 negative results obtained by 
the ISH, SB and PCR detection methods, which make up 
40% of the total number of results investigated.
It is probably due to the small number of samples 
used in the research and the very difficulty in detecting 
HPV in swabs and biopsy samples.
Among the factors that generate controversy about 
HPV prevalence in the normal oral mucosa seen on Table 
1, we can stress the large variation in HPV detection rates, 
from 0% to 100% despite the use of more sensitive methods 
-such as PCR; another factor is the relationship between 
results and sample sizes, which varied in 3 samples, with 
100% positiveness for HPV in the Tominaga et al.64 study 
from 1996, reaching up to 212 samples with 15% of HPV 
detection in the Kellokoski et al.65 study from 1992, thus 
showing a great difference between the results, which is 
probably due to a failure in the HPV detection methods 
or in harvesting the material or, even, because we do not 
know the exact HPV infection pathway in the normal oral 
mucosa32,13,16.
The human papillomavirus infection in oral cavity 
and oropharynx benign lesions (squamous cell papilloma, 
condilomas and verruca) in 25 results from 14 authors was 
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of HPV 6 and 11, in papillomas and in condilomas, through 
the following methods: IHQ, ISH and PCR; in oral warts, 
the prevalence was of 2 and 57, by the IHQ, ISH, HSB 
and PCR methods, with HPV 2 dominance. The presence 
of HPV is clear in all cases, varying from 13% to 100% in 
positiveness, with its prevalent types, according to the le-
sion, regardless of the methods used. It is very likely that 
this happens because these lesions bear a larger number 
of cells with HPV DNA. We could also see a dominance 
of low risk HPV, specially HPV 6 and 11 justified because 
they are the types most frequently associated with oral 
benign papillomatosis lesions29, whilst the high risk ones, 
like the HPV 16, only showed up in 3 results.
Table 3 depicts HPV prevalence in oral focal epi-
thelial hyperplasia in 7 results from 6 authors and it was 
HPV 13 and 32, through the many detection methods: 
IHQ, ISH, HSB and PCR, with a variation in HPV detection 
rates of 39% to 100%. We could also see that all results 
were HPV positive and in 2 cases the HPV was not typed, 
justified by the IHQ technique, what makes HPV evident 
in this disease.
Table 4 depicts a variation in HPV detection rates, 
from 0% to 74% in 24 results of oral cancer from 21 au-
thors: it is probably due to the different detection methods 
bearing different sensitivity and sample sizes used in the 
research, from 2 to 100 samples. Another factor is the dif-
ficulty in detecting HPV in oral cancer, due to the presence 
of such virus in only one subpopulation of cells and the 
low number of copies found in infected cells55.
Still in Table 4, we see a high HPV 16 prevalence 
through the ISH, HSB and PCR techniques, being present 
in 80% of all the results. HPV 16 rates detected varied in 
8%, in other words, 2 positive results from the 27 samples 
in the Wilczynski et al.62 (1998) study, and this suggests a 
huge discrepancy among the results. We could also see 
4 negative results for HPV by the IHQ and ISH methods, 
which is probably due to the low sensitivity of these 
methods when compared to PCR and the small sample 
size. Therefore, we still require more studies using dif-
ferent HPV detection methods to better confirm the virus 
presence in oral cancer.
HPV 16 presence in oral cancer in many studies 
depicted in Table 4 does not prove that the virus be indeed 
responsible for the disease, notwithstanding, it does prove 
that it may contribute to the incidence of oral cancer, spe-
cially among non-smokers and non-alcoholics3,45, or even 
in the simultaneous presence of chemical agents and HPV 
infection, which may lead to malignant transformation.
Other factors that contribute to increase HPV preva-
lence in the oral cavity and oropharynx are: a reduction 
in the patient’s immune response for the virus66, having 
more than one sexual partner and the practice of oral sex50 
- these all increase the likelihood of an HPV infection and 
its recurrence.
HPV 16 prevalence found in the oral cancer results 
(Table 4) and the normal oral mucosa (Table 1) suggests 
that HPV 16 is the one most prevalent in the oral mucosa 
and oropharynx. Comparing HPV prevalence between 
tables 1 and 4 could value the HPV relationship in the 
genesis of certain dysplasia. Notwithstanding, the results 
seen in the tables bring about controversies, which are 
attributed, mainly to the sensitivity variation of the meth-
ods employed, as well as the diversity of the populations 
studied and the sample sizes.
CONCLUSION
The literature analysis on the HPV prevalence in 
the oral cavity and oropharynx leads us to the following 
conclusions:
1. Among the techniques used to diagnose HPV, 
the most sensitive is PCR;
2. HPV prevalence in the normal oral mucosa 
presents discrepant results;
3. HPV prevalence in virus-related benign lesions 
is confirmed;
4. Despite HPV prevalence in oral cancer there 
still are controversies as to the virus presence and oral 
carcinogenesis;
5. Thus, more studies are necessary in order to 
enhance the methods used to detect HPV DNA and the 
sample collection techniques (swabs or biopsies), aiming 
at having less result interference and greater clarifica-
tions about HPV infection and its prevalence in both the 
oral cavity and the oropharynx, and we are motivated to 
continue the HPV research, especially in the normal oral 
mucosa and in oral cancer.
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